×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions for VYNE Therapeutics Inc. (VYNE)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VYNEVYNE Therapeutics Inc.Zeronda TylerChief Financial OfficerJan 02, 2024Option Exercise$2.2893212131,837Jan 03, 2024, 05:22 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerJan 02, 2024Option Exercise$2.28157358133,898Jan 03, 2024, 05:21 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCJan 02, 2024Option Exercise$2.28161367149,435Jan 03, 2024, 05:20 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEONov 30, 2023Option Exercise$2.812,2846,42646,168Dec 04, 2023, 04:30 PM
VYNEVYNE Therapeutics Inc.LEPORE PATRICK GDirectorNov 15, 2023Buy$3.9113,00050,77836,472Nov 17, 2023, 05:03 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerChief Financial OfficerOct 02, 2023Option Exercise$3.831,0874,1636,930Oct 04, 2023, 04:26 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerOct 02, 2023Option Exercise$3.831,1844,5359,055Oct 04, 2023, 04:23 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCOct 02, 2023Option Exercise$3.831,1544,42024,596Oct 04, 2023, 04:21 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOOct 02, 2023Option Exercise$3.838,54932,74343,884Oct 04, 2023, 04:19 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerChief Financial OfficerJun 30, 2023Option Exercise$4.10913738,017Jul 05, 2023, 04:37 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCMay 31, 2023Option Exercise$3.463,66412,66425,907Jun 02, 2023, 04:34 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOMay 31, 2023Option Exercise$3.462,7669,56053,414Jun 02, 2023, 04:31 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerChief Financial OfficerMar 31, 2023Option Exercise$3.083841,1838,108Apr 04, 2023, 05:07 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerMar 31, 2023Option Exercise$3.084801,47810,390Apr 04, 2023, 05:05 PM
VYNEVYNE Therapeutics Inc.LEPORE PATRICK GDirectorMar 20, 2023Buy$2.4820,00049,68023,472Mar 22, 2023, 04:03 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCMar 20, 2023Buy$2.5010,00025,00022,721Mar 22, 2023, 04:01 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCDec 31, 2022Option Exercise$0.151,813272229,144Jan 04, 2023, 05:12 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerDec 31, 2022Option Exercise$0.151,720258220,252Jan 04, 2023, 05:09 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerChief Financial OfficerDec 31, 2022Option Exercise$0.1535453173,005Jan 04, 2023, 05:05 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEODec 31, 2022Option Exercise$0.1510,6851,6031,064,290Jan 04, 2023, 05:03 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEONov 30, 2022Option Exercise$0.2034,7056,8611,074,975Dec 02, 2022, 04:30 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerCFOSep 30, 2022Option Exercise$0.2235379173,359Oct 04, 2022, 05:05 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerSep 30, 2022Option Exercise$0.221,719383221,972Oct 04, 2022, 05:05 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCSep 30, 2022Option Exercise$0.221,813404230,957Oct 04, 2022, 05:04 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOSep 30, 2022Option Exercise$0.2210,6832,3821,040,270Oct 04, 2022, 05:00 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerCFOJun 30, 2022Option Exercise$0.39354138173,712Jul 05, 2022, 05:01 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerJun 30, 2022Option Exercise$0.391,719669223,691Jul 05, 2022, 05:01 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCJun 30, 2022Option Exercise$0.391,813705232,770Jul 05, 2022, 05:00 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOJun 30, 2022Option Exercise$0.3910,6834,1561,050,953Jul 05, 2022, 05:00 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerCFOMay 31, 2022Option Exercise$0.3512,5104,332174,066Jun 02, 2022, 04:36 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOMay 31, 2022Option Exercise$0.3511,8874,1161,061,636Jun 02, 2022, 04:35 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerCFOMar 31, 2022Option Exercise$0.65773502161,556Apr 04, 2022, 05:10 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerMar 31, 2022Option Exercise$0.653,4692,255225,410Apr 04, 2022, 05:09 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCMar 31, 2022Option Exercise$0.653,6302,359234,583Apr 04, 2022, 05:09 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOMar 31, 2022Option Exercise$0.6523,18615,0711,049,749Apr 04, 2022, 05:08 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerDec 31, 2021Option Exercise$1.021,2501,275153,879Jan 04, 2022, 04:40 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCDec 31, 2021Option Exercise$1.021,4841,514163,213Jan 04, 2022, 04:40 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerInterim CFONov 30, 2021Option Exercise$0.884,1873,66687,535Dec 02, 2021, 05:08 PM
VYNEVYNE Therapeutics Inc.LEPORE PATRICK GDirectorNov 30, 2021Buy$1.0212,50012,69962,500Dec 02, 2021, 05:08 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEONov 30, 2021Option Exercise$0.884,7054,119767,520Dec 02, 2021, 05:07 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerInterim CFOSep 30, 2021Option Exercise$1.3920628683,348Oct 01, 2021, 05:12 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerSep 30, 2021Option Exercise$1.391,4802,057155,129Oct 01, 2021, 05:12 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCSep 30, 2021Option Exercise$1.391,4842,063164,697Oct 01, 2021, 05:11 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOSep 30, 2021Option Exercise$1.3913,09618,203762,815Oct 01, 2021, 05:10 PM
VYNEVYNE Therapeutics Inc.LEPORE PATRICK GDirectorAug 25, 2021Buy$1.6012,50020,00050,000Aug 26, 2021, 05:04 PM
VYNEVYNE Therapeutics Inc.PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% OwnerAug 16, 2021Sale$1.74250,000435,0004,935,057Aug 18, 2021, 07:19 PM
VYNEVYNE Therapeutics Inc.EDELMAN JOSEPH10% OwnerAug 13, 2021Sale$1.84250,000460,0005,185,057Aug 17, 2021, 04:46 PM
VYNEVYNE Therapeutics Inc.PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% OwnerAug 12, 2021Sale$2.23338,897755,7405,435,057Aug 16, 2021, 06:24 PM
VYNEVYNE Therapeutics Inc.Zeronda TylerInterim CFOJun 30, 2021Option Exercise$3.517002,45722,695Jul 02, 2021, 04:37 PM
VYNEVYNE Therapeutics Inc.Wiley Matthew T.Chief Commercial OfficerJun 30, 2021Option Exercise$3.515,15118,080109,246Jul 02, 2021, 04:36 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerJun 30, 2021Option Exercise$3.513,08310,82195,750Jul 02, 2021, 04:36 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCJun 30, 2021Option Exercise$3.513,55112,464105,322Jul 02, 2021, 04:36 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOJun 30, 2021Option Exercise$3.5118,85966,195455,599Jul 02, 2021, 04:35 PM
VYNEVYNE Therapeutics Inc.LEPORE PATRICK GDirectorMay 26, 2021Buy$3.6012,50044,95837,500May 27, 2021, 05:18 PM
VYNEVYNE Therapeutics Inc.PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% OwnerMay 06, 2021Sale$3.671,000,0003,670,0005,773,954May 07, 2021, 05:31 PM
VYNEVYNE Therapeutics Inc.Wiley Matthew T.Chief Commercial OfficerMar 31, 2021Option Exercise$6.842,57317,599114,397Apr 02, 2021, 12:15 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerMar 31, 2021Option Exercise$6.841,94513,30498,833Apr 02, 2021, 12:14 PM
VYNEVYNE Therapeutics Inc.Saik AndrewChief Financial OfficerMar 31, 2021Option Exercise$6.847625,212113,451Apr 02, 2021, 12:14 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCMar 31, 2021Option Exercise$6.841,76512,073108,873Apr 02, 2021, 12:14 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOMar 31, 2021Option Exercise$6.846,31643,201473,517Apr 02, 2021, 12:13 PM
VYNEVYNE Therapeutics Inc.LEPORE PATRICK GDirectorMar 15, 2021Buy$7.4112,50092,56325,000Mar 16, 2021, 04:38 PM
VYNEVYNE Therapeutics Inc.EDELMAN JOSEPH10% OwnerJan 28, 2021Buy$2.374,219,4099,999,99927,095,819Feb 01, 2021, 05:31 PM
VYNEVYNE Therapeutics Inc.Wiley Matthew T.Chief Commercial OfficerDec 31, 2020Option Exercise$1.581,5412,435357,181Jan 05, 2021, 04:32 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEODec 31, 2020Option Exercise$1.589,65615,2561,304,334Jan 05, 2021, 04:32 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerDec 31, 2020Option Exercise$1.582,3783,757286,262Jan 05, 2021, 12:00 AM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCDec 31, 2020Option Exercise$1.581,8222,879325,703Jan 05, 2021, 12:00 AM
VYNEVYNE Therapeutics Inc.LEPORE PATRICK GDirectorDec 03, 2020Buy$1.7150,00085,42550,000Dec 07, 2020, 04:31 PM
VYNEVYNE Therapeutics Inc.Wiley Matthew T.Chief Commercial OfficerNov 30, 2020Option Exercise$1.457,83811,326358,722Dec 02, 2020, 04:31 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCNov 30, 2020Option Exercise$1.4510,46015,115327,525Dec 02, 2020, 04:31 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEONov 30, 2020Option Exercise$1.454,2636,1601,313,990Dec 02, 2020, 04:30 PM
VYNEVYNE Therapeutics Inc.Wiley Matthew T.Chief Commercial OfficerSep 30, 2020Option Exercise$1.661,5412,558350,884Oct 02, 2020, 04:32 PM
VYNEVYNE Therapeutics Inc.Stuart IainChief Scientific OfficerSep 30, 2020Option Exercise$1.662,3783,947288,640Oct 02, 2020, 04:32 PM
VYNEVYNE Therapeutics Inc.Harsch MutyaChief Legal Officer and GCSep 30, 2020Option Exercise$1.661,8223,025317,065Oct 02, 2020, 04:31 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOSep 30, 2020Option Exercise$1.666,23910,3571,309,727Oct 02, 2020, 04:31 PM
VYNEVYNE Therapeutics Inc.Saik AndrewChief Financial OfficerSep 08, 2020Buy$1.4640,00058,480340,000Sep 08, 2020, 08:01 PM
VYNEVYNE Therapeutics Inc.Domzalski DavidPresident and CEOSep 08, 2020Buy$1.3875,000103,5681,315,966Sep 08, 2020, 08:00 PM
MNLOMenlo Therapeutics Inc.BARBARI SHARONDirectorAug 20, 2020Option Exercise$1.4875,000111,00075,000Aug 21, 2020, 05:00 PM
MNLOMenlo Therapeutics Inc.Wiley Matthew T.Chief Commercial OfficerJun 30, 2020Option Exercise$1.731,5412,666352,425Jul 02, 2020, 04:25 PM
MNLOMenlo Therapeutics Inc.Stuart IainChief Scientific OfficerJun 30, 2020Option Exercise$1.732,3784,114291,018Jul 02, 2020, 04:25 PM
MNLOMenlo Therapeutics Inc.Harsch MutyaChief Legal Officer and GCJun 30, 2020Option Exercise$1.731,8223,152318,887Jul 02, 2020, 04:24 PM
MNLOMenlo Therapeutics Inc.Domzalski DavidPresident and CEOJun 30, 2020Option Exercise$1.736,23910,7931,240,966Jul 02, 2020, 04:22 PM
MNLOMenlo Therapeutics Inc.EDELMAN JOSEPHDirectorJun 09, 2020Buy$1.852,702,7024,999,99922,876,410Jun 11, 2020, 07:33 PM
MNLOMenlo Therapeutics Inc.Wiley Matthew T.Chief Commercial OfficerApr 06, 2020Option Exercise$1.409081,271203,967Apr 07, 2020, 05:23 PM
MNLOMenlo Therapeutics Inc.Stuart IainChief Scientific OfficerApr 06, 2020Option Exercise$1.403,7635,268180,901Apr 07, 2020, 05:22 PM
MNLOMenlo Therapeutics Inc.Harsch MutyaChief Legal Officer and GCApr 06, 2020Option Exercise$1.404,4746,264170,712Apr 07, 2020, 05:22 PM
MNLOMenlo Therapeutics Inc.Domzalski DavidPresident and CEOApr 06, 2020Option Exercise$1.4011,77216,481567,213Apr 07, 2020, 05:21 PM
MNLOMenlo Therapeutics Inc.Harsch MutyaChief Legal Officer and GCMar 31, 2020Option Exercise$2.681,6884,52456,503Apr 02, 2020, 04:47 PM
MNLOMenlo Therapeutics Inc.Wiley Matthew T.Chief Commercial OfficerMar 31, 2020Option Exercise$2.685251,40767,051Apr 02, 2020, 04:41 PM
MNLOMenlo Therapeutics Inc.Stuart IainChief Scientific OfficerMar 31, 2020Option Exercise$2.681,9405,19959,452Apr 02, 2020, 04:41 PM
MNLOMenlo Therapeutics Inc.Domzalski DavidPresident and CEOMar 31, 2020Option Exercise$2.684,45611,942187,496Apr 02, 2020, 04:32 PM
MNLOMenlo Therapeutics Inc.BALL KRISTINE MSee RemarksDec 11, 2019Option Exercise$4.5227,766125,50252,534Dec 16, 2019, 05:14 PM
MNLOMenlo Therapeutics Inc.Kwon PaulChief Scientific OfficerDec 11, 2019Option Exercise$4.5227,766125,50252,534Dec 16, 2019, 05:13 PM
MNLOMenlo Therapeutics Inc.Basta Steven LChief Executive OfficerDec 11, 2019Option Exercise$4.1499,210410,769509,764Dec 16, 2019, 05:11 PM
MNLOMenlo Therapeutics Inc.Kwon PaulChief Scientific OfficerDec 11, 2019Option Exercise$4.5227,766125,50252,534Dec 13, 2019, 09:59 PM
MNLOMenlo Therapeutics Inc.Krasnow Ronald A.See RemarksDec 11, 2019Option Exercise$4.528,27137,38515,819Dec 13, 2019, 09:58 PM
MNLOMenlo Therapeutics Inc.BALL KRISTINE MSee RemarksDec 11, 2019Option Exercise$4.5227,766125,50252,534Dec 13, 2019, 09:56 PM
MNLOMenlo Therapeutics Inc.Basta Steven LChief Executive OfficerDec 11, 2019Option Exercise$4.1499,210410,769509,764Dec 13, 2019, 09:54 PM
MNLOMenlo Therapeutics Inc.Watson James FFormer 10% OwnerJul 24, 2018Sale$7.6512,50095,62548,910Jul 26, 2018, 07:11 PM
MNLOMenlo Therapeutics Inc.Watson James FFormer 10% OwnerJul 24, 2018Sale$7.65487,5003,729,3751,907,568Jul 26, 2018, 07:11 PM
MNLOMenlo Therapeutics, Inc.venBio Global Strategic Fund II L.P.10% OwnerJan 25, 2018Buy$17.00265,0004,505,000265,000Jan 29, 2018, 04:22 PM